Amundi Asset Management US’s Amicus Therapeutics FOLD Stock Holding History

Amundi Asset Management US’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$173K	Hold	17,500	–	–	﹤0.01%	1473
2020 Q4	$404K	Hold	17,500	–	–	﹤0.01%	1326
2020 Q3	$247K	Hold	17,500	–	–	﹤0.01%	1362
2020 Q2	$264K	Hold	17,500	–	–	﹤0.01%	1340
2020 Q1	$162K	Hold	17,500	–	–	﹤0.01%	1366
2019 Q4	$170K	Hold	17,500	–	–	﹤0.01%	1503
2019 Q3	$140K	Buy	17,500 +3,800	+28%	+$41.2K	﹤0.01%	1527
2019 Q2	$171K	Hold	13,700	–	–	﹤0.01%	1498
2019 Q1	$186K	Hold	13,700	–	–	﹤0.01%	1450
2018 Q4	$131	Sell	13,700 -9,200	-40%	-$101K	﹤0.01%	1461
2018 Q3	$277K	Buy	+22,900	New	+$320K	﹤0.01%	1430

Other funds holding FOLD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return